Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

PLD is an effective and safer alternative for treating breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

No definitive link between finasteride and male breast cancer, but further research is needed.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Common skin conditions can greatly affect a person's mental health and social life.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.